What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Gene
- Disease
Her primary areas of investigation include Immunology, Atypical hemolytic uremic syndrome, Alternative complement pathway, Complement system and Factor H.
Her Immunology research is multidisciplinary, incorporating perspectives in Thrombotic microangiopathy and Kidney disease.
Her research in Atypical hemolytic uremic syndrome intersects with topics in Microangiopathic hemolytic anemia, Eculizumab, Preeclampsia and Internal medicine, Disease.
Her Complement system study which covers Complement that intersects with Haemolytic-uraemic syndrome, C3-convertase and End stage renal disease.
Her study in Factor H is interdisciplinary in nature, drawing from both Membranoproliferative glomerulonephritis, Glomerulonephritis and Haplotype.
Her biological study spans a wide range of topics, including Mutation and Complement factor B.
Her most cited work include:
- Complement System Part I - Molecular Mechanisms of Activation and Regulation. (594 citations)
- Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival (566 citations)
- Atypical hemolytic uremic syndrome (419 citations)
What are the main themes of her work throughout her whole career to date?
Véronique Frémeaux-Bacchi mostly deals with Immunology, Atypical hemolytic uremic syndrome, Complement system, Internal medicine and Alternative complement pathway.
Many of her studies on Immunology involve topics that are commonly interrelated, such as Transplantation.
The Atypical hemolytic uremic syndrome study combines topics in areas such as Thrombotic microangiopathy, Disease, Complement factor B, Eculizumab and Hemolytic anemia.
Her Complement system study combines topics from a wide range of disciplines, such as Molecular biology and Complement.
Her Internal medicine research includes themes of Gastroenterology and Endocrinology.
Her Alternative complement pathway study combines topics in areas such as Membranoproliferative glomerulonephritis, Glomerulonephritis and Glomerulopathy.
She most often published in these fields:
- Immunology (52.32%)
- Atypical hemolytic uremic syndrome (35.57%)
- Complement system (28.61%)
What were the highlights of her more recent work (between 2016-2021)?
- Immunology (52.32%)
- Complement system (28.61%)
- Atypical hemolytic uremic syndrome (35.57%)
In recent papers she was focusing on the following fields of study:
Immunology, Complement system, Atypical hemolytic uremic syndrome, Internal medicine and Eculizumab are her primary areas of study.
Within one scientific family, she focuses on topics pertaining to Glomerulopathy under Immunology, and may sometimes address concerns connected to Kidney disease and Nephrotic syndrome.
Her primary area of study in Complement system is in the field of Alternative complement pathway.
Her Atypical hemolytic uremic syndrome study incorporates themes from Complement factor I, Discontinuation, Factor H, Hazard ratio and CD46.
Her Internal medicine research is multidisciplinary, relying on both Gastroenterology, Endocrinology and Streptococcus pneumoniae.
Véronique Frémeaux-Bacchi interconnects Thrombotic microangiopathy, Disease, Retrospective cohort study, Kidney transplantation and Dialysis in the investigation of issues within Eculizumab.
Between 2016 and 2021, her most popular works were:
- Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference (254 citations)
- Haemolytic uraemic syndrome. (181 citations)
- Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation (91 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
